Original article
Cardiovascular
Determinants and Prognosis of Myocardial Damage After Coronary Artery Bypass Grafting

https://doi.org/10.1016/j.athoracsur.2004.07.060Get rights and content

Background

Myocardial infarction remains a devastating complication after coronary revascularization. Although electrocardiography (ECG) and echocardiography suggest transmural infarction, myocardial damage and the quality of myocardial protection are not recognized unless troponin I (TnI) is assessed. Determinants and prognosis of TnI elevation after coronary artery bypass grafting (CABG) were evaluated.

Methods

Data of 776 consecutive patients undergoing CABG between January 2002 and January 2004 were prospectively exposed to univariate and multivariate analysis. We evaluated the prognosis of patients with all the ECG, echocardiographic, and biochemical criteria for acute myocardial infarction and that of patients with only TnI elevation. Twelve-month follow-up survival and freedom from cardiac events (FCE) were accomplished.

Results

Troponin I greater than 3.1 μg/L at 12 hours was detected in 6.9% of the population, and correlated with lower in-hospital (p < 0.001) and follow-up survival (p = 0.00001), and lower FCE (p = 0.0009). Twenty-one (38.8%) of these fulfilled ECG-echocardiographic criteria (p = 0.05), demonstrating higher TnI values at 12 (p = 0.001), 24 (p = 0.01), 48 (p = 0.01), and 72 (p = 0.04) hours, prolonged ventilation time (p = 0.001), higher in hospital mortality (p = 0.003), lower follow-up survival (p = 0.023), and lower FCE (p = 0.0084). A EuroSCORE greater than 6, ongoing unstable angina, aortic cross-clamp time greater than 90 minutes, cardiopulmonary bypass time greater than 180 minutes, incomplete revascularization, and intraoperative intraaortic balloon pump were independent predictors of myocardial damage (MD) at multivariate analysis. Combined antegrade and retrograde cardioplegia and postoperative enoximone infusion were associated with a lower TnI elevation.

Conclusions

Troponin I greater than 3.1 μg/L at 12 hours defines perioperative MD. Associated ECG-echocardiographic criteria indicate acute myocardial infarction and anticipate a worse outcome. Identification of predictors for MD is important to develop preventative strategies, as antegrade plus retrograde cardioplegia and enoximone infusion.

Section snippets

Material and Methods

A total of 776 consecutive adult patients undergoing primary isolated coronary artery bypass grafting between January 2002 and January 2004 were prospectively enrolled in the study. Fifty-eight perioperative risk factors analyzed by univariate and multivariate stepwise logistic regression are listed in the Appendix.

Of preoperative variables, number and type of diseased vessels were determined based on the angiography of the patient. The left anterior descending, left circumflex, right coronary

Results

The overall incidence of postoperative TnI elevation greater than 3.1 μ:g/L was 6.9% (54 of 776 patients). Only 21 (38.8%) of these fulfilled ECG or echocardiographic criteria for perioperative AMI (p = 0.05). Compared to patients with only TnI elevation, those with ECG and echocardiographic criteria demonstrated a higher value of TnI at 12, 24, 48, and 72 hours postsurgery (Fig 1), a more prolonged ventilation time (81 ± 34.5 hours vs 27.9 ± 25.1; p = 0.001), and a higher in-hospital mortality

Comment

Despite advances in surgical skill, intraoperative techniques and devices, and postoperative management, perioperative myocardial infarction is still a life-threatening complication after isolated myocardial revascularization, responsible for early and late cardiovascular events and mortality 1, 2. In the last few years, the introduction of new biochemical markers of myocardial damage, such as the isoforms T and I of troponin, with their higher sensitivity and specificity in diagnosing such

References (22)

  • M. Riha et al.

    Off pump coronary artery bypass grafting in EuroSCORE high and low risk patients

    Eur J Cardiothorac Surg

    (2002)
  • Cited by (94)

    • Presence of Intracardiac Thrombus at the Time of Left Ventricular Assist Device Implantation Is Associated With an Increased Risk of Stroke and Death

      2021, Journal of Cardiac Failure
      Citation Excerpt :

      It is also conceivable that the presence of an ICT reflects an underlying hypercoagulable state that may predispose to the formation of additional thrombi in the context of LVAD implantation.19 Prolonged CPB time has been previously associated with higher morbidity and mortality.20–22 In our analyses, we found that CPB time was significantly longer in patients with ICT.

    • Diagnostic dilemma of perioperative myocardial infarction after coronary artery bypass grafting: A review

      2020, International Journal of Surgery
      Citation Excerpt :

      As previously shown, Q waves are predictive for ischemic changes in particular if accompanied by enzyme elevation. Onorati et al., in their prospective study, showed that patients with TnI elevation and associated ECG or echocardiographic changes had a lower survival and lower freedom of cardiac events compared to TnI elevation only (38.5 ± 14.8% vs 72.7 ± 15.0%; p = 0.023) [57]. As there is no comprehensive single test available, this seems currently the most promising method to rule out ischemia mimicking signs.

    • Detecting patients with PMI post-CABG based on cardiac troponin-T profiles: A latent class mixed modeling approach

      2020, Clinica Chimica Acta
      Citation Excerpt :

      Several studies have focused on the release profile (or kinetics) of cTn post-CABG, arguing that insight in the normal postoperative release profile can aid clinicians in recognizing patients with PMI and that timing of the peak is relevant when applying cut-off values [10–12]. Aside from the normal post-operative CABG cTn release profile, studies describe profiles for off-pump CABG (OPCAB) surgery [10,11,13] and surgeries complicated by PMI [10–12,14–17]. While these studies demonstrate the variability in cTn release profiles and their value in recognizing PMI, they a priori define subgroups based on clinical characteristics or outcomes and subsequently evaluate cTn profiles.

    View all citing articles on Scopus
    View full text